Harnessing pre-existing immunity to enhance the immunogenicity of an adjuvant-free, immuno-targeting subunit vaccine against SARS-CoV-2
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202112GSM
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$13,825Funder
Canadian Institutes of Health Research (CIHR)Research Location
CanadaLead Research Institution
University of TorontoResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
ImmunitySpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified